Skip to main content
Livermore
Livermore
ZHEN

ING Groep NV

SEC CIK
0001039765
Latest filing
Aug 13, 2026

DGX holding history

Quest Diagnostics Inc in every 13F filed by ING Groep NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DGX overviewAll 13F holders of DGXFull Q2 2026 holdings

Shares (Q2 2026)
17,294
Value
$3.67M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of DGX by ING Groep NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,294$3.67M<0.1%+1,938+12.6%AddedHolders
Q1 202615,356$3.01M<0.1%−1,753−10.2%ReducedHolders
Q4 202517,109$2.97M<0.1%+461+2.8%AddedHolders
Q3 202516,648$3.17M<0.1%+16,648NewHolders
Q2 20250$00.0%−13,074−100.0%Sold outHolders
Q1 202513,074$2.21M<0.1%+2,764+26.8%AddedHolders
Q4 202410,310$1.56M<0.1%−33,477−76.5%ReducedHolders
Q3 202443,787$6.80M<0.1%+4,340+11.0%AddedHolders
Q2 202439,447$5.40M<0.1%−43,609−52.5%ReducedHolders
Q1 202483,056$11.1M0.1%+76,163+1,104.9%AddedHolders
Q4 20236,893$950.4K<0.1%−6,897−50.0%ReducedHolders
Q3 202313,790$1.68M<0.1%+13,790NewHolders
Q2 20230$00.0%−18,862−100.0%Sold outHolders
Q1 202318,862$2.67M<0.1%+3,698+24.4%AddedHolders
Q4 202215,164$2.37M<0.1%+10,888+254.6%AddedHolders
Q3 20224,276$525.0K<0.1%−17,810−80.6%ReducedHolders
Q2 202222,086$2.94M<0.1%+20,206+1,074.8%AddedHolders
Q1 20221,880$257.0K<0.1%−14,131−88.3%ReducedHolders
Q4 202116,011$2.77M<0.1%+5,753+56.1%AddedHolders
Q3 202110,258$1.49M<0.1%+10,258NewHolders
Q2 20210$00.0%−8,836−100.0%Sold outHolders
Q1 20218,836$1.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.